Neratinib Recruiting Phase 2 Trials for Glioblastomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02977780INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)